Business Standard

Wednesday, January 08, 2025 | 06:17 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Page 7 - Cadila Healthcare

Cadila Healthcare: US FDA resolution key for re-rating

Recent brand acquisition will help boost domestic sales

Cadila Healthcare: US FDA resolution key for re-rating
Updated On : 30 Dec 2016 | 12:27 AM IST

Cadila develops India's first virus like particle vaccine for treating flu

CPL Biologicals, which has developed the vaccine, is a JV between Cadila and US-based Novavax

Cadila develops India's first virus like particle vaccine for treating flu
Updated On : 17 Nov 2016 | 6:10 PM IST

Strong US business to drive Cadila Healthcare growth

Analysts believe growth worries for the base business are behind it and expect H2 to be much better

Strong US business to drive Cadila Healthcare growth
Updated On : 01 Nov 2016 | 11:49 PM IST

Cadila Healthcare gains ahead of presenting new data of Saroglitazar

The scrip had also outperformed the market in past one quarter, rising 18.84% as against Sensex's 0.26% decline

Cadila Healthcare gains ahead of presenting new data of Saroglitazar
Updated On : 01 Nov 2016 | 10:14 AM IST

Cadila Healthcare dips on disappointing Q2 profit

The stock dipped 8% to Rs 374 after the company reported 29% YoY drop in its consolidated net profit at Rs 338 crore in Q2FY17.

Cadila Healthcare dips on disappointing Q2 profit
Updated On : 26 Oct 2016 | 1:39 PM IST

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA

The EIR report is given to an establishment after the completion of an inspection by the USFDA

Cadila Healthcare gets EIR for Ahmedabad plant from USFDA
Updated On : 02 Sep 2016 | 12:07 PM IST

Cadila Healthcare gains on EIR for Ahmedabad facility

The stock moved higher by 4% to Rs 391 on the BSE.

Cadila Healthcare gains on EIR for Ahmedabad facility
Updated On : 02 Sep 2016 | 10:41 AM IST

Cadila Healthcare gets EIR from US FDA for Changodar facility

Last month, the firm received EIR for its manufacturing facility in Moraiya

Cadila Healthcare gets EIR from US FDA for Changodar facility
Updated On : 16 Aug 2016 | 11:44 AM IST

Launches could revive Cadila health

Solving problems relating to its Moraiya unit will be key

Launches could revive Cadila health
Updated On : 04 Aug 2016 | 11:33 PM IST

Cadila shares jump 9.5% despite disappointing Q1 show

At NSE, shares of the company surged 9.21 per cent to Rs 379.75

Cadila shares jump 9.5% despite disappointing Q1 show
Updated On : 04 Aug 2016 | 12:12 PM IST

Cadila Healthcare surges post Q1 results

The stock surged nearly 10% to Rs 380 on the BSE after the management guided for 12-15 launches over FY17.

Cadila Healthcare surges post Q1 results
Updated On : 04 Aug 2016 | 11:44 AM IST

Cadila Healthcare Q1 net dips 23% to Rs 356 crore

Shares of the company closed at Rs 347 on BSE, down 0.22% from the previous close

Cadila Healthcare Q1 net dips 23% to Rs 356 crore
Updated On : 03 Aug 2016 | 6:52 PM IST

Cadila Healthcare: More triggers awaited

Resolution of US FDA issues of 2014 is positive

Cadila Healthcare: More triggers awaited
Updated On : 11 Jul 2016 | 11:41 PM IST

Cadila Healthcare gains on USFDA nod for anti-diabetic drug

The stock moved higher by 5% to Rs 375 on the BSE.

Cadila Healthcare gains on USFDA nod for anti-diabetic drug
Updated On : 11 Jul 2016 | 12:19 PM IST

Cadila eyes growth opportunity in US, Latin America formulation markets

The pharma major is also planning to enhance its share in US generics market by launching complex, oral solids and formulations

Cadila eyes growth opportunity in US, Latin America formulation markets
Updated On : 10 Jul 2016 | 1:56 PM IST

Cadila eyes growth opportunity in US, LatAm formulation mkts

During 2015-16, the company's business in the US remained the largest contributor to the consolidated revenue, which crossed $600 million in sales for the first time

Cadila eyes growth opportunity in US, LatAm formulation mkts
Updated On : 10 Jul 2016 | 1:09 PM IST

Cadila Healthcare gets EIR from USFDA for Moraiya facility

The company has received Establishment Inspection Report which indicates closure of inspection points of initial review

Cadila Healthcare gets EIR from USFDA for Moraiya facility
Updated On : 08 Jul 2016 | 4:41 PM IST

Alembic Pharma, Cadila Healthcare gain on getting EIR from USFDA

Alembic Pharma and Cadila Healthcare were up 4% each as compared to 0.18% fall in Sensex at 01:38 PM.

Alembic Pharma, Cadila Healthcare gain on getting EIR from USFDA
Updated On : 08 Jul 2016 | 1:50 PM IST

Cadila: Concerns over US, India growth remain

With little clarity on timing of Moraiya plant clearance by FDA, gains from product launches might get delayed

Cadila: Concerns over US, India growth remain
Updated On : 14 May 2016 | 1:37 AM IST

Cadila Healthcare gains on USFDA nod for anti-diabetic drug

The company has received final approval from the USFDA for Glyburide and Metformin Hcl tablets USP

Cadila Healthcare gains on USFDA nod for anti-diabetic drug
Updated On : 01 Mar 2016 | 2:05 PM IST